Showing results (41-50 of 81) with videos related to

Sort By:
Pageof 9
British Journal of Cancer|September 11, 2003
Irinotecan plus leucovorin-modulated 5-fluorouracil I.V. bolus every other week may be a suitable therapeutic option also for elderly patients with metastatic colorectal carcinomaP Comella, A Farris, V Lorusso, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 7, 2005
A 2-month cisplatin-epirubicin-paclitaxel (PET) weekly combination as primary systemic therapy for large operable breast cancer: a phase II studyG Frasci, G D'Aiuto, P Comella, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 10, 2000
Oxaliplatin and raltitrexed combined with leucovorin-modulated 5-fluorouracil i.v. bolus every two weeks: a dose finding study in advanced previously treated colorectal carcinoma. Southern Italy Cooperative Oncology GroupP Comella, F De Vita, L De Lucia, et al.
Cancer|March 26, 1999
A phase II trial of cisplatin, methotrexate, levofolinic acid, and 5-fluorouracil in the treatment of patients with locally advanced, metastatic squamous cell carcinoma of the head and neckF Caponigro, P Comella, P Marcolin, et al.
Cancer Chemotherapy and Pharmacology|May 20, 2005
Biweekly oxaliplatin combined with oral capecitabine (OXXEL regimen) as first-line treatment of metastatic colorectal cancer patients: a Southern Italy Cooperative Oncology Group phase II studyP Comella, B Massidda, S Palmeri, et al.
British Journal of Cancer|July 22, 2004
Gemcitabine with either paclitaxel or vinorelbine vs paclitaxel or gemcitabine alone for elderly or unfit advanced non-small-cell lung cancer patientsP Comella, G Frasci, P Carnicelli, et al.
Cancer|January 3, 2001
Cisplatin, dacarbazine, and fotemustine plus interferon alpha in patients with advanced malignant melanoma. A multicenter phase II study of the Italian Cooperative Oncology GroupA Daponte, P A Ascierto, A Gravina, et al.
British Journal of Cancer|October 19, 2006
Weekly cisplatin, epirubicin, and paclitaxel with granulocyte colony-stimulating factor support vs triweekly epirubicin and paclitaxel in locally advanced breast cancer: final analysis of a sicog phase III studyG Frasci, G D'Aiuto, P Comella, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Etoposide, doxorubicin and cisplatin (EAP) treatment in advanced gastric carcinoma: a multicentre study of the Italian Trials in Medical Oncology (I.T.M.O.) GroupE Bajetta, M Di Bartolomeo, F de Braud, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 6, 1999
Concurrent irinotecan and 5-fluorouracil plus levo-folinic acid given every other week in the first-line management of advanced colorectal carcinoma: a phase I study of the Southern Italy Cooperative Oncology GroupP Comella, R Casaretti, F De Vita, et al.
Pageof 9